Fish Oil Attenuates Omega-6 Polyunsaturated Fatty Acid-Induced Dysbiosis and Infectious Colitis but Impairs LPS Dephosphorylation Activity Causing Sepsis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Ghosh, Sanjoy ^a   DeCoffe, Daniella ^a   Brown, Kirsty ^a   Rajendiran, Ethendhar ^a   Estaki, Mehrbod ^a   Dai, Chuanbin ^a   Yip, Ashley ^a   Gibson, Deanna L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; FISH OIL; INTERLEUKIN 15; LIPOPOLYSACCHARIDE BINDING PROTEIN; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE; OMEGA 6 FATTY ACID; TUMOR NECROSIS FACTOR;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIACEAE; CELL INFILTRATION; CITROBACTER RODENTIUM; COLITIS; CONTROLLED STUDY; DEPHOSPHORYLATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; IMMUNOCOMPETENT CELL; INTESTINE FLORA; LACTOBACILLUS; LIPID COMPOSITION; MICROBIAL IMMUNITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; SEPSIS; STOMACH PROTECTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DIET; DIETARY SUPPLEMENT; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY;

ALKALINE PHOSPHATASE; ANIMALS; CITROBACTER RODENTIUM; COLITIS; DIET; DIETARY SUPPLEMENTS; DINOPROSTONE; ENTEROBACTERIACEAE INFECTIONS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FISH OILS; INTERLEUKIN-15; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873563309     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055468     Document Type: Article

References (49)

1. Brown K, Decoffe D, Molcan E, Gibson DL, (2012) Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012, 4, 1095-1119
2. Ghosh S, Dai C, Brown K, Rajendiran E, Makarenko S, et al. (2011) Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am J Physiol Gastrointest Liver Physiol 301: G39-49.
3. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, et al. (2007) Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131: 33-45.
4. Baker J, Brown K, Rajendiran E, Yip A, DeCoffe D, et al. (2012) Medicinal lavender modulates the enteric microbiota to protect against Citrobacter rodentium-induced colitis. Am J Physiol Gastrointest Liver Physiol 303: G825-836.
5. Statistics C (2006) Food Statistics 2005.
6. Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM, (2010) n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 104: 1586-1600.
7. Ma X, Torbenson M, Hamad AR, Soloski MJ, Li Z, (2008) High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin Exp Immunol 151: 130-138.
8. Tjonneland A, Overvad K, Bergmann MM, Nagel G, Linseisen J, et al. (2009) Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 58: 1606-1611.
9. Simopoulos AP, Leaf A, Salem N Jr, (1999) Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab 43: 127-130.
10. Gray-Donald K, Jacobs-Starkey L, Johnson-Down L, (2000) Food habits of Canadians: reduction in fat intake over a generation. Can J Public Health 91: 381-385.
11. Simopoulos AP, (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70: 560S-569S.
12. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, et al. (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71: 179S-188S.
13. Belluzzi A, (2004) Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment. Eur Rev Med Pharmacol Sci 8: 225-229.
14. Uchiyama K, Nakamura M, Odahara S, Koido S, Katahira K, et al. (2010) N-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. Inflamm Bowel Dis 16: 1696-1707.
15. Chapkin RS, Davidson LA, Ly L, Weeks BR, Lupton JR, et al. (2007) Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J Nutr 137: 200S-204S.
16. Innis SM, Dai C, Wu X, Buchan AM, Jacobson K, (2010) Perinatal lipid nutrition alters early intestinal development and programs the response to experimental colitis in young adult rats. Am J Physiol Gastrointest Liver Physiol 299: G1376-1385.
17. Matsunaga H, Hokari R, Kurihara C, Okada Y, Takebayashi K, et al. (2008) Omega-3 fatty acids exacerbate DSS-induced colitis through decreased adiponectin in colonic subepithelial myofibroblasts. Inflamm Bowel Dis 14: 1348-1357.
18. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104: 13780-13785.
19. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ, (2006) Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 44: 4136-4141.
20. Mondot S, Kang S, Furet JP, Aguirre de Carcer D, McSweeney C, et al. (2011) Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis 17: 185-192.
21. Sokol H, Lepage P, Seksik P, Dore J, Marteau P, (2006) Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol 44: 3172-3177.
22. Monteleone I, Pallone F, Monteleone G, (2011) Th17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med 9: 122.
23. Duck LW, Walter MR, Novak J, Kelly D, Tomasi M, et al. (2007) Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis 13: 1191-1201.
24. Bassaganya-Riera J, Hontecillas R, Beitz DC, (2002) Colonic anti-inflammatory mechanisms of conjugated linoleic acid. Clin Nutr 21: 451-459.
25. Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, et al. (2004) Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127: 777-791.
26. Todorov SD, Furtado DN, Saad SM, Tome E, Franco BD (2011) Potential beneficial properties of bacteriocin-producing lactic acid bacteria isolated from smoked salmon. J Appl Microbiol.
27. Ley RE, Turnbaugh PJ, Klein S, Gordon JI, (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
28. Gibson DL, Ma C, Bergstrom KS, Huang JT, Man C, et al. (2008) MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol 10: 618-631.
29. Gibson DL, Ma C, Rosenberger CM, Bergstrom KS, Valdez Y, et al. (2008) Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol 10: 388-403.
30. Gallay P, Carrel S, Glauser MP, Barras C, Ulevitch RJ, et al. (1993) Purification and characterization of murine lipopolysaccharide-binding protein. Infect Immun 61: 378-383.
31. Orinska Z, Maurer M, Mirghomizadeh F, Bulanova E, Metz M, et al. (2007) IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med 13: 927-934.
32. Bates JM, Akerlund J, Mittge E, Guillemin K, (2007) Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2: 371-382.
33. Chen KT, Malo MS, Moss AK, Zeller S, Johnson P, et al. (2010) Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. Am J Physiol Gastrointest Liver Physiol 299: G467-475.
34. Goldberg RF, Austen WG Jr, Zhang X, Munene G, Mostafa G, et al. (2008) Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U S A 105: 3551-3556.
35. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, et al. (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334: 1557-1560.
36. Wan JM, Grimble RF, (1987) Effect of dietary linoleate content on the metabolic response of rats to Escherichia coli endotoxin. Clin Sci (Lond) 72: 383-385.
37. Andoh A, Tsujikawa T, Ishizuka I, Araki Y, Sasaki M, et al. (2003) N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int J Mol Med 12: 721-725.
38. Mane J, Pedrosa E, Loren V, Ojanguren I, Fluvia L, et al. (2009) Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice. J Nutr 139: 603-610.
39. Gravaghi C, La Perle KM, Ogrodwski P, Kang JX, Quimby F, et al. (2011) Cox-2 expression, PGE(2) and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice. J Nutr Biochem 22: 360-365.
40. Dong L, Li J, Liu Y, Yue W, Luo X (2011) TLR2mAb or/and TLR4mAb Increase Counts of Lactobacilli and Bifidobacteria in Dextran Sulfate Sodium-Induced Colitis in Mice. J Gastroenterol Hepatol.
41. Gareau MG, Wine E, Reardon C, Sherman PM, (2010) Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J Infect Dis 201: 81-91.
42. Hummel S, Veltman K, Cichon C, Sonnenborn U, Schmidt MA, (2012) Differential targeting of the E-Cadherin/beta-Catenin complex by gram-positive probiotic lactobacilli improves epithelial barrier function. Appl Environ Microbiol 78: 1140-1147.
43. Natividad JM, Petit V, Huang X, de Palma G, Jury J, et al. (2012) Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1(-/-);Nod2(-/-) Mice. Inflamm Bowel Dis 18: 1434-1446.
44. Woodworth HL, McCaskey SJ, Duriancik DM, Clinthorne JF, Langohr IM, et al. (2010) Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis. Cancer Res 70: 7960-7969.
45. Ma C, Wickham ME, Guttman JA, Deng W, Walker J, et al. (2006) Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell Microbiol 8: 1669-1686.
46. Villar J, Perez-Mendez L, Espinosa E, Flores C, Blanco J, et al. (2009) Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PLoS One 4: e6818.
47. Ward PA, (2007) The curiosity of IL-15. Nat Med 13: 903-904.
48. Gibson DL, Montero M, Ropeleski MJ, Bergstrom KS, Ma C, et al. (2010) Interleukin-11 reduces TLR4-induced colitis in TLR2-deficient mice and restores intestinal STAT3 signaling. Gastroenterology 139: 1277-1288.
49. Baykov AA, Evtushenko OA, Avaeva SM, (1988) A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem 171: 266-270.